Isabelita Vengco
Overview
Explore the profile of Isabelita Vengco including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
130
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Janosky M, Sabado R, Cruz C, Vengco I, Hasan F, Winer A, et al.
J Immunother Cancer
. 2017 Aug;
2(1):32.
PMID: 28837000
Studies suggest that conventional cancer therapies given after immunotherapy (IT) can boost antitumor immunity and possibly improve response rates and progression-free survival. We report two cases of metastatic breast cancer...
2.
Sabado R, Pavlick A, Gnjatic S, Cruz C, Vengco I, Hasan F, et al.
Cancer Immunol Res
. 2015 Jan;
3(3):278-287.
PMID: 25633712
The Toll-like receptor (TLR) 7/8 agonist resiquimod has been used as an immune adjuvant in cancer vaccines. We evaluated the safety and immunogenicity of the cancer testis antigen NY-ESO-1 given...
3.
Sabado R, Miller E, Spadaccia M, Vengco I, Hasan F, Bhardwaj N
J Vis Exp
. 2013 Aug;
(78).
PMID: 23928481
While clinical studies have established that antigen-loaded DC vaccines are safe and promising therapy for tumors, their clinical efficacy remains to be established. The method described below, prepared in accordance...
4.
Xiong Z, Gharagozlou S, Vengco I, Chen W, Ohlfest J
Clin Cancer Res
. 2008 Sep;
14(17):5484-93.
PMID: 18765540
Purpose: Breast cancer patients with brain metastasis have a dismal prognosis. We determined the ability of immunostimulatory CpG oligodeoxynucleotides (ODN) to treat or prevent brain metastasis in a mouse model....
5.
Ohlfest J, Demorest Z, Motooka Y, Vengco I, Oh S, Chen E, et al.
Mol Ther
. 2005 Sep;
12(5):778-88.
PMID: 16150649
Glioblastoma is a fatal brain tumor that becomes highly vascularized by secreting proangiogenic factors and depends on continued angiogenesis to increase in size. Consequently, a successful antiangiogenic therapy should provide...